5-Chloro-1-[2-(4-methyl-piperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxylic acid 4-(4-butyryl-5-methyl-pyrazol-1-yl)-phenyl ester

ID: ALA3325895

Chembl Id: CHEMBL3325895

PubChem CID: 118711247

Max Phase: Preclinical

Molecular Formula: C30H32ClN5O4

Molecular Weight: 562.07

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C

Standard InChI:  InChI=1S/C30H32ClN5O4/c1-4-5-28(37)25-17-32-36(20(25)2)22-7-9-23(10-8-22)40-30(39)26-18-35(27-11-6-21(31)16-24(26)27)19-29(38)34-14-12-33(3)13-15-34/h6-11,16-18H,4-5,12-15,19H2,1-3H3

Standard InChI Key:  MFTNUFUMHSJQIL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3325895

    ---

Associated Targets(Human)

P2RY12 Tclin Purinergic receptor P2Y12 (2369 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2ry12 Purinergic receptor P2Y12 (121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.07Molecular Weight (Monoisotopic): 561.2143AlogP: 4.76#Rotatable Bonds: 8
Polar Surface Area: 89.67Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.96CX LogP: 4.51CX LogD: 4.38
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.17Np Likeness Score: -1.60

References

1. Boldron C, Besse A, Bordes MF, Tissandié S, Yvon X, Gau B, Badorc A, Rousseaux T, Barré G, Meneyrol J, Zech G, Nazare M, Fossey V, Pflieger AM, Bonnet-Lignon S, Millet L, Briot C, Dol F, Hérault JP, Savi P, Lassalle G, Delesque N, Herbert JM, Bono F..  (2014)  N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist.,  57  (17): [PMID:25075638] [10.1021/jm500588w]

Source